Jiangxi Fushine Pharmaceutical Co.,Ltd. Posted 33.6 Million Yuan Net Loss in First Quarter of 2023

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net loss of 33.6 million yuan in the first quarter of 2023, reversing a net profit of 23.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 397.9 million yuan in revenue, down 1.1% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 45.4%.